GGrantIndex
← Leaderboards

Andrew Y Koh

Sloan-Kettering Inst Can Research

$4,547,928
Attributed
$6,593,291
Total exposure
5
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.6M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,571,111 · 6

By mechanism

R01$5,093,045 · 2
P01$4,977,820 · 1
K08$619,000 · 1
K24$592,052 · 1
R41$289,194 · 1

Top collaborators

Most similar at Sloan-Kettering Inst Can Research

Same institution · by research overlap

Others in their field

Top investigators on “Gut Microbiota

Research focus

Gut MicrobiotaMicrobialMalignant NeoplasmsImmuneInsightCancer PatientGrantImmune SystemImmune ResponseIntestinesPreventLeadCheckpoint TherapyImmunocompromised HostMolecularPre-ClinicalMicrobiotaGut MicrobiomeAdultMicrobiomeCancer ImmunotherapyImmune Checkpoint InhibitorInnovationLaboratories

Grant awards (26)

Understanding the molecular mechanisms regulating fungal colonization and disease in the mammalian intestinal niche$2,450,410
P01 · FY2025 · AI
Understanding the molecular mechanisms regulating fungal colonization and disease in the mammalian intestinal niche$2,527,410
P01 · FY2024 · AI
Mentoring Patient Oriented Research in the Microbiome of Cancer and Stem Cell Transplant Patients$115,395
K24 · FY2024 · AI · contact PI
Role of Gut Microbiota in Modulating Immune Checkpoint Inhibitory Therapy for Cancer$516,179
R01 · FY2023 · CA · contact PI
Mentoring Patient Oriented Research in the Microbiome of Cancer and Stem Cell Transplant Patients$116,891
K24 · FY2023 · AI · contact PI
Role of Gut Microbiota in Modulating Immune Checkpoint Inhibitory Therapy for Cancer$73,448
R01 · FY2023 · CA · contact PI
Role of Gut Microbiota in Modulating Immune Checkpoint Inhibitory Therapy for Cancer$584,177
R01 · FY2022 · CA · contact PI
A Novel Bacterially-derived Product to Enhance Immunity and Response to Immune Checkpoint Therapy$289,194
R41 · FY2022 · AI · contact PI
Mentoring Patient Oriented Research in the Microbiome of Cancer and Stem Cell Transplant Patients$118,387
K24 · FY2022 · AI · contact PI
Role of Gut Microbiota in Modulating Immune Checkpoint Inhibitory Therapy for Cancer$74,947
R01 · FY2022 · CA · contact PI
Role of Gut Microbiota in Modulating Immune Checkpoint Inhibitory Therapy for Cancer$596,098
R01 · FY2021 · CA · contact PI
Mentoring Patient Oriented Research in the Microbiome of Cancer and Stem Cell Transplant Patients$119,884
K24 · FY2021 · AI · contact PI
Role of Gut Microbiota in Modulating Immune Checkpoint Inhibitory Therapy for Cancer$596,098
R01 · FY2020 · CA · contact PI
Candida Albicans Gastrointestinal Colonization and Dissemination$405,000
R01 · FY2020 · AI · contact PI
Mentoring Patient Oriented Research in the Microbiome of Cancer and Stem Cell Transplant Patients$121,495
K24 · FY2020 · AI · contact PI
Role of Gut Microbiota in Modulating Immune Checkpoint Inhibitory Therapy for Cancer$627,098
R01 · FY2019 · CA · contact PI
Candida Albicans Gastrointestinal Colonization and Dissemination$405,000
R01 · FY2019 · AI · contact PI
Candida Albicans Gastrointestinal Colonization and Dissemination$405,000
R01 · FY2018 · AI · contact PI
Candida Albicans Gastrointestinal Colonization and Dissemination$405,000
R01 · FY2017 · AI · contact PI
Candida Albicans Gastrointestinal Colonization and Dissemination$405,000
R01 · FY2016 · AI · contact PI
Mucosal colonization and dissemination of P. aeruginosa$93,536
K08 · FY2009 · AI · contact PI
Mucosal colonization and dissemination of P. aeruginosa$34,584
K08 · FY2009 · AI · contact PI
Mucosal colonization and dissemination of P. aeruginosa$128,120
K08 · FY2008 · AI · contact PI
Mucosal colonization and dissemination of P. aeruginosa$128,120
K08 · FY2007 · AI · contact PI
Mucosal colonization and dissemination of P. aeruginosa$117,320
K08 · FY2006 · AI · contact PI
Mucosal colonization and dissemination of P. aeruginosa$117,320
K08 · FY2005 · AI